These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073 [Abstract] [Full Text] [Related]
4. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors. Sarris AH, Talpaz M, Deisseroth AB, Estrov Z. Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668 [Abstract] [Full Text] [Related]
5. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. Newman A, Clutterbuck RD, Powles RL, Catovsky D, Millar JL. Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443 [Abstract] [Full Text] [Related]
6. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD. Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711 [Abstract] [Full Text] [Related]
8. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells. Kim HP, Gerhard B, Harasym TO, Mayer LD, Hogge DE. Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609 [Abstract] [Full Text] [Related]
12. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors. Lemoli RM, Gulati SC. Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748 [Abstract] [Full Text] [Related]
14. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G. Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879 [Abstract] [Full Text] [Related]
15. Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells. de Jonge-Peeters SD, van der Weide K, Kuipers F, Sluiter WJ, de Vries EG, Vellenga E. Ann Hematol; 2009 Jun; 88(6):573-80. PubMed ID: 19002460 [Abstract] [Full Text] [Related]
16. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. Kufner S, Zitzelsberger H, Kroell T, Pelka-Fleischer R, Salem A, de Valle F, Schweiger C, Nuessler V, Schmid C, Kolb HJ, Schmetzer HM. Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128 [Abstract] [Full Text] [Related]
17. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ. Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [Abstract] [Full Text] [Related]
19. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P. Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [Abstract] [Full Text] [Related]